2019

Podcasts

Reimagining Liquid Biopsy Applications with Epigenomics

Samuel Levy, PhD, CSO, Bluestar Genomics

Samuel Levy of Bluestar Genomics speaks to CHI on March 13, 2019. Dr. Levy will be speaking during The Liquid Biopsy Summit, June 17-19, in San Francisco, CA.

Topics include cell-free diagnostics in precision medicine, transformation & growth in the liquid biopsy field, epigenomic assays for cancer detection, and opportunities ahead.

2017

Interviews

“Built-In Truth”: NIST, RNA Standards and the Joint Initiative for Metrology in Biology

Sarah A. Munro, Ph.D., Team Leader, Genome-Scale Measurements Group, Joint Initiative for Metrology in Biology, National Institute of Standards and Technology (NIST)

Download Interview

Podcasts

Cancer Metastasis: Treatment Challenges, Therapy Improvements and New Medical Devices for Targeting It

Stuart S. Martin, Ph.D., Professor of Physiology, Greenebaum NCI Comprehensive Cancer Center, University of Maryland School of Medicine

Stuart S. Martin of University of Maryland School of Medicine speaks to Cambridge Healthtech Institute on March 17, 2017. He will be a presenter and short course instructor during The Liquid Biopsy Summit, June 21-23 in San Francisco, California.

For more information, please visit www.LiquidBiopsySummit.com/

Topics Include: limitations of clinical imaging and detection of metastatic disease, detection of circulating cell-free DNA and RNA, immune system therapies, capture of live CTCs, the problem of tumor evolution, and more.

2016

Interviews

Oncology Diagnostics Strategies at Genentech

Rebecca (Becky) Suttmann, MS, Senior Scientific Researcher, Oncology Biomarker Development, Genentech, Inc.

Download Interview

Podcasts

The Potential of Extracellular RNAs as Biomarkers and a Liquid Biopsy Approach

Muneesh Tewari, M.D., Ph.D., Associate Professor, Internal Medicine and Biomedical Engineering & Ray and Ruth Anderson-Laurence M. Sprague Memorial Research Professor, University of Michigan Health System

Muneesh Tewari of the University of Michigan speaks to Cambridge Healthtech Institute on April 28, 2016. Dr. Tewari will give his keynote presentation during the conference program at The Liquid Biopsy Summit, June 22-24 in San Francisco, California.

Topics Include: circulating extracellular RNAs as a liquid biopsy approach, developing novel biomarker methods that involve serial monitoring at high-time resolution, and researching circulating microRNA biomarkers for cancer and other diseases with a diverse scientific and medical background.

For more information, please visit www.LiquidBiopsySummit.com/

Molecular Diagnostics and Liquid Biopsy Sample Prep: Development, Refinements and Opportunities

Jamie Platt, Ph.D., MB(ASCP), Founder & Managing Director, BRIDGenomics, LLC

Jamie Platt of BRIDGenomics, LLC speaks to Cambridge Healthtech Institute on April 21, 2016. Dr. Platt will give her presentation during the conference program at The Liquid Biopsy Summit, June 22-24 in San Francisco, California.

Topics Include: changes in the landscape of development and commercialization of molecular diagnostics, issues and emerging opportunities for liquid biopsy sample prep, and process/technology refinements necessary for broader, routine application of liquid biopsies.

For more information, please visit www.LiquidBiopsySummit.com/


Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag